Column Group’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.9M | Hold |
3,540,777
| – | – | 54.68% | 1 |
|
|
2025
Q1 | $19.8M | Hold |
3,540,777
| – | – | 44.67% | 1 |
|
|
2024
Q4 | $28.6M | Hold |
3,540,777
| – | – | 51.26% | 1 |
|
|
2024
Q3 | $36.3M | Hold |
3,540,777
| – | – | 52.16% | 1 |
|
|
2024
Q2 | $25M | Hold |
3,540,777
| – | – | 35.12% | 2 |
|
|
2024
Q1 | $48.7M | Sell |
3,540,777
-27,404
| -0.8% | -$377K | 30.33% | 2 |
|
|
2023
Q4 | $32.8M | Hold |
3,568,181
| – | – | 21.69% | 2 |
|
|
2023
Q3 | $21.6M | Hold |
3,568,181
| – | – | 14.33% | 4 |
|
|
2023
Q2 | $27.7M | Hold |
3,568,181
| – | – | 10.75% | 5 |
|
|
2023
Q1 | $20.3M | Hold |
3,568,181
| – | – | 7.35% | 5 |
|
|
2022
Q4 | $21M | Hold |
3,568,181
| – | – | 7% | 4 |
|
|
2022
Q3 | $11.4M | Hold |
3,568,181
| – | – | 2.53% | 6 |
|
|
2022
Q2 | $16M | Hold |
3,568,181
| – | – | 3.4% | 6 |
|
|
2022
Q1 | $19.1M | Hold |
3,568,181
| – | – | 3.53% | 6 |
|
|
2021
Q4 | $52.5M | Sell |
3,568,181
-1,200,000
| -25% | -$17.6M | 7.13% | 5 |
|
|
2021
Q3 | $99.7M | Hold |
4,768,181
| – | – | 11.34% | 3 |
|
|
2021
Q2 | $84.3M | Hold |
4,768,181
| – | – | 11.94% | 5 |
|
|
2021
Q1 | $117M | Hold |
4,768,181
| – | – | 11.19% | 4 |
|
|
2020
Q4 | $161M | Buy |
+4,768,181
| New | +$161M | 14.64% | 3 |
|